Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Clinical trial NCT02154490 · COMPLETED
Trial details
- NCT number
- NCT02154490
- Sponsor
- SWOG Cancer Research Network
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-07-08
- Primary completion
- 2022-04-01
- Enrollment
- 1864
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.